Eko Murmur Analysis Software (EMAS) vs Eko Low Ejection Fraction Tool (ELEFT)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 75/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

These tools are adjacent competitors, both leveraging Eko digital stethoscopes and AI for cardiac screening. Tool A (EMAS) specializes in detecting and differentiating heart murmurs, offering a freemium model for basic analysis. Tool B (ELEFT) focuses specifically on identifying low ejection fraction, a key indicator of heart failure, and is part of an enterprise platform.

Choose Eko Murmur Analysis Software (EMAS) if…

Choose Eko Murmur Analysis Software (EMAS) if your primary goal is to accurately detect and differentiate various heart murmurs, including distinguishing between innocent and structural types, in both adult and pediatric patients. This tool is ideal for clinicians seeking early clinical decision support for a broad spectrum of potential heart and lung diseases indicated by murmurs.

View Eko Murmur Analysis Software (EMAS) →

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if your specific objective is the early identification of patients at risk for heart failure by detecting low ejection fraction during routine physical examinations. This enterprise-level solution is best suited for healthcare systems aiming to proactively screen and manage populations for heart failure risk.

View Eko Low Ejection Fraction Tool (ELEFT) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Eko Murmur Analysis Software (EMAS) Eko Low Ejection Fraction Tool (ELEFT)
Pricing Starts at $119.99 per year for eko+ membership; enterprise solutions require contacting sales. Unknown
Deployment Cloud-based, Mobile App Unknown
BAA Available Yes AI-estimated Unknown
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Unknown

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Murmur Analysis Software (EMAS)

Tool A (EMAS) offers a free basic AI analysis via a mobile app, making it highly accessible for individual clinicians. Its explicit mention of recording, playback, annotation, and sharing features, along with EHR compatibility, suggests a user-friendly experience. Tool B (ELEFT) is part of an enterprise solution, which may imply a more complex setup, though it boasts quick results.

Clinical Value

Tie

Both tools offer significant clinical value by providing FDA-cleared AI for early detection of critical cardiac conditions. EMAS differentiates innocent and structural heart murmurs across adult and pediatric patients, while ELEFT aids in the early detection of low ejection fraction, a key indicator of heart failure, in approximately 15 seconds. Both address high-impact clinical needs.

Pricing & Value

Eko Murmur Analysis Software (EMAS)

Tool A (EMAS) provides a free basic AI analysis with the Eko App, offering immediate value and transparent pricing for core functionality. Full features and telehealth capabilities require paid subscriptions. Tool B (ELEFT) requires contacting sales for pricing and is positioned as an enterprise solution, indicating less transparency and likely higher costs for individual users.

Enterprise Readiness

Eko Low Ejection Fraction Tool (ELEFT)

Both tools are FDA-cleared, HIPAA compliant, and have BAAs, demonstrating foundational enterprise readiness. However, Tool B (ELEFT) is explicitly stated to be 'part of Eko's SENSORAu2122 platform, an enterprise solution,' indicating its design and positioning are specifically for institutional adoption and large-scale deployments.

Innovation

Eko Low Ejection Fraction Tool (ELEFT)

Both tools are innovative in their application of AI to cardiac auscultation. Tool B (ELEFT) stands out by enabling the detection of low ejection fraction, a complex physiological parameter indicative of heart failure, from a routine physical exam in approximately 15 seconds. This non-invasive screening for a condition traditionally requiring imaging represents a significant leap in early heart failure detection.

Support & Docs

Tie

Both tools are products of Eko Health and would leverage the company's comprehensive support infrastructure. Eko Health provides a help center with FAQs, user manuals, video tutorials, and various contact options (phone, email, chat) for its products. Specific user manuals are available for both EMAS and ELEFT. Without specific differentiating factors in support for each individual tool, they are considered a tie.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Murmur Analysis Software (EMAS) Eko Low Ejection Fraction Tool (ELEFT)
Name Eko Murmur Analysis Software (EMAS) Eko Low Ejection Fraction Tool (ELEFT)
Primary Function / Key Detection Detects and differentiates heart murmurs (innocent and structural) Aids in early detection of low ejection fraction (indicator of heart failure)
Company Eko Devices Eko Health
Data Analyzed Heart sound (PCG) and optional ECG data ECG and heart sound recordings
Specialties Cardiology, Internal Medicine, Pediatrics Cardiology, Family Medicine, Internal Medicine

Videos

Demos, reviews, and walkthroughs featuring Eko Murmur Analysis Software (EMAS) and Eko Low Ejection Fraction Tool (ELEFT).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

EMAS is an FDA-cleared AI tool designed to detect and differentiate heart murmurs in adult and pediatric patients, offering clinical decision support for early detection of heart and lung disease. ELEFT, also FDA-cleared, is an AI algorithm that aids clinicians in the early detection of low ejection fraction, a key indicator of heart failure, during routine physical exams.
EMAS analyzes heart sound (PCG) and optional ECG data to detect and differentiate heart murmurs. ELEFT analyzes both ECG and heart sound recordings to provide results for low ejection fraction detection in approximately 15 seconds.
EMAS is explicitly cleared by the FDA for detecting and differentiating heart murmurs in both adult and pediatric patients. ELEFT's description focuses on aiding in the early detection of low ejection fraction, a key indicator of heart failure, without specific mention of pediatric use.
EMAS is a cloud-based service accessed via a mobile application, offering PDF report generation and sharing that is EHR compatible. ELEFT is part of the SENSORAu2122 Cardiac Early Detection Platform, an enterprise solution designed for cloud-based data processing and storage, aiding in early identification of heart failure risk.
EMAS is listed for Cardiology, Internal Medicine, and Pediatrics. ELEFT is intended for Cardiology, Family Medicine, and Internal Medicine, highlighting its utility in broader primary care settings for early heart failure risk identification.
Both EMAS and ELEFT integrate with FDA-cleared Eko digital stethoscopes. EMAS specifically mentions integration with Eko digital stethoscopes such as CORE 500u2122, DUO, and CORE, while ELEFT generally states integration with Eko digital stethoscopes.

Backers

Who funded each tool's parent company.

Eko Murmur Analysis Software (EMAS)

Eko Low Ejection Fraction Tool (ELEFT)

AI Tool Finder
AI-powered search. Results may not be comprehensive.